Alpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes

Journal of Cellular Physiology

Volumn 216, Issue 2, 2008, Pages 486-497

  Han, Chang ^a   Bowen, William C ^a   Michalopoulos, George K ^a   Wu, Tong ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PHENYLEPHRINE; PRAZOSIN; RGS2 PROTEIN; STAT3 PROTEIN; STEROID RECEPTOR COACTIVATOR 1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; EXPRESSION VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; TRANSACTIVATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEPATOCYTES; HUMANS; MALE; PHENYLEPHRINE; PRAZOSIN; RATS; RATS, INBRED F344; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ADRENERGIC, ALPHA-1; RGS PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 46049097373     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21420     Document Type: Article

References (69)

1. Allen LF, Lefkowitz RJ, Caron MG, Cotecchia S. 1991. G-protein-coupled receptor genes as protooncogenes: Constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA 88:11354-11358.
2. Bertelsen LS, Barrett KE, Keely SJ. 2004. Gs protein-coupled receptor agonists induce transactivation of the epidermal growth factor receptor in T84 cells: Implications for epithelial secretory responses. J Biol Chem 279:6271-6279.
3. Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM. 1998. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391:285-288.
4. Boluyt MO, Zheng JS, Younes A, Long X, O'Neill L, Silverman H, Lakatta EG, Crow MT. 1997. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ Res 81:176-186.
5. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE, Jr. 1999. Stat3 as an oncogene. Cell 98:295-303.
6. Broten J, Michalopoulos G, Petersen B, Cruise J. 1999. Adrenergic stimulation of hepatocyte growth factor expression. Biochem Biophys Res Commun 262:76-79.
7. Bylund DB, Blaxall HS, Iversen LJ, Caron MG, Lefkowitz RJ, Lomasney JW. 1992. Pharmacological characteristics of alpha 2-adrenergic receptors: Comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1-5.
8. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Jr., Trendelenburg U. 1994. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136.
9. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. 2003. STAT proteins: From normal control of cellular events to tumorigenesis. J Cell Physiol 197:157-168.
10. Chen L, Xin X, Eckhart AD, Yang N, Faber JE. 1995. Regulation of vascular smooth muscle growth by alpha 1-adrenoreceptor subtypes in vitro and in situ. J Biol Chem 270:30980-30988.
11. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383.
12. Cruise JL, Michalopoulos G. 1985. Norepinephrine and epidermal growth factor: Dynamics of their interaction in the stimulation of hepatocyte DNA synthesis. J Cell Physiol 125: 45-50.
13. Cruise JL, Houck KA, Michalopoulos GK. 1985. Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science 227:749-751.
14. Cruise JL, Knechtle SJ, Bollinger RR, Kuhn C, Michalopoulos G. 1987. Alpha 1-adrenergic effects and liver regeneration. Hepatology 7:1189-1194.
15. Deighan C, Woollhead AM, Colston JF, McGrath JC. 2004. Hepatocytes from alpha1B-adrenoceptor knockout mice reveal compensatory adrenoceptor subtype substitution. Br J Pharmacol 142:1031-1037.
16. Exton JH. 1980. Mechanisms involved in alpha-adrenergic phenomena: Role of calcium ions in actions of catecholamines in liver and other tissues. Am J Physiol 238:E3-E12.
17. Gao B. 2005. Cytokines, STATs and liver disease. Cell Mol Immunol 2:92-100.
18. Garcia-Sainz JA, Romero-Avila MT, Torres-Marquez ME. 1995. Characterization of the human liver alpha 1-adrenoceptors: Predominance of the alpha 1A subtype. Eur J Pharmacol 289:81-86.
19. Gong G, Waris G, Tanveer R, Siddiqui A. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA 98:9599-9604.
20. Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A. 2001. Cell communication networks: Epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20:1594-1600.
21. Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H, Okuyama T, Takeda K, Akira S, Ogino T, Irani K, Ozaki M. 2003. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 112:989-998.
22. Han C, Demetris AJ, Stolz DB, Xu L, Lim K, Wu T. 2006a. Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2- controlled prostaglandin E2 signaling pathway. J Biol Chem 281:24831-24846.
23. Han C, Michalopoulos GK, Wu T. 2006b. Prostaglandin E2 receptor EPI transactivates EGFR/ MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol 207:261-270.
24. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massague J. 2000. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100:229-240.
25. Hein P, Michel MC. 2007. Signal transduction and regulation: Are all alpha1-adrenergic receptor subtypes created equal? Biochem Pharmacol 73:1097-1106.
26. Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP, Ruffolo RR, Jr. 1995. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: Consensus update. Pharmacol Rev 47:267-270.
27. Hirasawa A, Awaji T, Xu Z, Shinoura H, Tsujimoto G. 2001. Regulation of subcellular localization of alpha1-adrenoceptor subtypes. Life Sci 68:2259-2267.
28. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B. 2002. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: Involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21:32-43.
29. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B. 2004. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40:933-941.
30. Hu ZW, Shi XY, Lin RZ, Hoffman BB. 1996. Alpha1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis. J Biol Chem 271:8977-8982.
31. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M. 2004. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10:168-174.
32. Knopp J, Macho L, Fickova M, Zorad S, Kvetnansky R, Jaroscakova I. 1997. Insulin and catecholamines act at different stages of rat liver regeneration. Ann NY Acad Sci 827:489-493.
33. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. 2000. Increased toxin-induced liver injury and fibrosis in interieukin-6-deficient mice. Hepatology 31:149-159.
34. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R. 2001. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276:26605-26613.
35. Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T. 2003. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: Evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 38:756-768.
36. Levy DE, Darnell JE, Jr. 2002. Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662.
37. Li W, Liang X, Kellendonk C, Poli V, Taub R. 2002. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411-28417.
38. Liang H, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. 1999. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J Biol Chem 274:19846-19851.
39. Lindroos PM, Zarnegar R, Michalopoulos GK. 1991. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 13:743-750.
40. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y, Bartholomeusz G, Shih JY, Hung MC. 2005. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7:575-589.
41. Lopez-Gimenez JF, Canals M, Pediani JD, Milligan G. 2007. The alpha1b-adrenoceptor exists as a higher-order oligomer: Effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 71:1015-1029.
42. Ma YC, Huang J, Ali S, Lowry W, Huang XY. 2000. Src tyrosine kinase is a novel direct effector of G proteins. Cell 102:635-646.
43. Michalopoulos GK, DeFrances MC. 1997. Liver regeneration. Science 276:60-66.
44. Michalopoulos GK, DeFrances M. 2005. Liver regeneration. Adv Biochem Eng Biotechnol 93:101-134.
45. Minneman KP. 1988. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacol Rev 40:87-119.
46. Minneman KP, Esbenshade TA. 1994. Alpha 1-adrenergic receptor subtypes. Annu Rev Pharmacol Toxicol 34:117-133.
47. Nguyen VA, Gao B. 1999. Cross-talk between alpha(1B)-adrenergic receptor (alpha(1B)AR) and interleukin-6 (IL-6) signaling pathways. Activation of alpha(1b)AR inhibits il-6-activated STAT3 in hepatic cells by a p42/44 mitogen-activated protein kinase-dependent mechanism. J Biol Chem 274:35492-35498.
48. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, Smedh U, Moran TH, Li Z, Huang J, Thomas SA, Diehl AM. 2004. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 53:438-445.
49. Olsen PS, Poulsen SS, Kirkegaard P. 1985. Adrenergic effects on secretion of epidermal growth factor from Brunner's glands. Gut 26:920-927.
50. Perez DM. 2007. Structure-function of alpha1-adrenergic receptors. Biochem Pharmacol 73:1051-1062.
51. Radaeva S, Sun R, Pan HN, Hong F, Gao B. 2004. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39:1332-1342.
52. Ruan Y, Kan H, Parmentier JH, Fatima S, Allen LF, Malik KU. 1998. Alpha-1A adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase D in rat-1 fibroblasts: Inhibition by protein kinase A. J Pharmacol Exp Ther 284:576-585.
53. Runge D, Runge DM, Jager D, Lubecki KA, Beer Stolz D, Karathanasis S, Kietzmann T, Strom SC, Jungermann K, Fleig WE, Michalopoulos GK. 2000. Serum-free, long-term cultures of human hepatocytes: Maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem Biophys Res Commun 269:46-53.
54. Rybin VO, Guo J, Gertsberg Z, Elouardighi H, Steinberg SF. 2007. Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes. J Biol Chem 282:23631-23638.
55. Sah VP, Hoshijima M, Chien KR, Brown JH. 1996. Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J Biol Chem 271:31185-31190.
56. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ. 1999. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29:403-411.
57. Sancho-Bru P, Bataller R, Colmenero J, Gasull X, Moreno M, Arroyo V, Brenner DA, Gines P. 2006. Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 291:G877-G884.
58. Schaper F, Siewert E, Gomez-Lechon MJ, Gatsios P, Sachs M, Birchmeier W, Heinrich PC, Castell J. 1997. Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/ APRF transcription factor in human hepatoma cells and hepatocytes. FEBS Lett 405:99-103.
59. Seglen PO. 1976. Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83.
60. Spector MS, Auer KL, Jarvis WD, Ishac EJ, Gao B, Kunos G, Dent P. 1997. Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes. Mol Cell Biol 17:3556-3565.
61. Thomas SM, Brugge JS. 1997. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513-609.
62. Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R. 1999. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 19:7519-7528.
63. Wang Z, Wang M, Carr BI. 1998. The inhibitory effect of interleukin 1 beta on rat hepatocyte DNA synthesis is mediated by nitric oxide. Hepatology 28:430-435.
64. Waris G, Huh KW, Siddiqui A. 2001. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 21:7721-7730.
65. Williams NG, Zhong H, Minneman KP. 1998. Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J Biol Chem 273:24624-24632.
66. Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, Sawyer DB. 2002. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282:C926-C934.
67. Xing M, Insel PA. 1996. Protein kinase C-dependent activation of cytosolic phospholipase A2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells. J Clin Invest 97:1302-1310.
68. Yamauchi J, Hirasawa A, Miyamoto Y, Kokubu H, Nishii H, Okamoto M, Sugawara Y, Tsujimoto G, Itoh H. 2002. Role of Dbl's big sister in the anti-mitogenic pathway from alpha1B-adrenergic receptor to c-jun N-terminal kinase. Biochem Biophys Res Commun 296:85-92.
69. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R. 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83.